This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Ryosuke Kojima: Innovator in Prokinetic Agent Screening
Introduction
Ryosuke Kojima is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of screening methods for prokinetic agents. His work aims to address diseases associated with abnormalities in 5-HT production and secretion.
Latest Patents
Kojima holds a patent for a screening method that provides a tool for obtaining substances useful as prophylactic and therapeutic drugs for various digestive organ diseases. This includes conditions such as constipation type irritable bowel syndrome, functional dyspepsia, constipation, diarrhea type irritable bowel syndrome, diarrhea, and vomiting. His innovative approach is crucial for advancing treatment options in this area.
Career Highlights
Kojima is currently employed at Astellas Pharma GmbH, where he continues to contribute to pharmaceutical research and development. His expertise in screening methods has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Kojima has collaborated with esteemed colleagues, including Katsura Nozawa and Hitoshi Doihara. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Ryosuke Kojima's work in developing screening methods for prokinetic agents represents a significant advancement in the treatment of digestive organ diseases. His contributions continue to influence the pharmaceutical industry and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile